Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study
Latest Information Update: 14 May 2024
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preeclampsia
- Focus Therapeutic Use
- Acronyms PROGRESS
- 09 May 2024 Planned End Date changed from 31 Jan 2024 to 31 Jan 2026.
- 09 May 2024 Planned primary completion date changed from 31 Jan 2024 to 31 Jan 2026.
- 05 Jan 2022 Planned End Date changed from 31 Jan 2022 to 31 Jan 2024.